Clinical Trial Update: Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial assessing the anti-inflammatory effects of Norflo Oro in acute relapses of HLA-B27 associated autoimmune uveitis has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Norflo Oro

Snippet

Sponsor: Eye Pharma | Conditions: Uveitis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-03-28